Axogen
AXGN
#4666
Rank
$2.17 B
Marketcap
$40.99
Share price
0.10%
Change (1 day)
246.49%
Change (1 year)
Categories

P/E ratio for Axogen (AXGN)

P/E ratio as of May 2026 (TTM): -64.7

According to Axogen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -64.6508. At the end of 2025 the company had a P/E ratio of -99.2.

P/E ratio history for Axogen from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-99.232.4%
2024-74.9
2019-24.2-29%
2018-34.1-63.9%
2017-94.3382.15%
2016-19.6103.48%
2015-9.62

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Medtronic
MDT
21.2-132.75%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
24.2-137.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
22.0-134.01%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.